Journal of Medicinal Chemistry · 1998 · 20 citations · 10 references
Life SciencesMedicinal ChemistryPharmacologyAntimicrobial ResistanceDrug DiscoveryStructure-activity RelationshipsAntibacterial AgentsAntibacterial PharmacologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsResistance In Gram-negative BacteriaAntibiotic DiscoveryAntibiotic Mechanisms Of ActionMacrolide AntibioticsMacrolide Resistance MechanismsMacrolide TherapyNovel Antibacterial AgentsNovel Antibacterial Drug Discovery
A series of 3-descladinosyl-2,3-anhydro-6- O -methylerythromycin A 11,12-cyclic carbazate analogues was prepared and evaluated for antibacterial activity. These 2,3-anhydro macrolides were found to be potent antibacterial agents in vitro against macrolide-susceptible organisms including Staphylococcus aureus 6538P, Streptococcus pyogenes EES61, and Streptococcus pneumoniae ATCC6303. These compounds were also very active against some organisms that show macrolide resistance ( S. aureus A5177, S. pyogenes PIU2584, and S. pneumoniae 5649). The compounds generally showed poor activity against organisms with constitutive MLS resistance. Selected compounds were evaluated in vivo in mouse protection studies. Although most of the compounds tested in vivo showed poor efficacy, two compounds, 38 and 57, were more active than clarithromycin against S. pneumoniae ATCC6303.
10
G. Michael Bright, A. Nagel, Jon Bordner et al. · The Journal of Antibiotics · 1988 · 238 citations · Full text
Acid degradation of erythromycin A and erythromycin B
Paul Kurath, Peter H. Jones, Richard S. Egan et al. · Cellular and Molecular Life Sciences · 1971 · 199 citations · Full text
William R. Baker, Jerry D. Clark, Richard Stephens et al. · The Journal of Organic Chemistry · 1988 · 94 citations
Jerry M. Zuckerman, Kenneth M. Kaye · Infectious Disease Clinics of North America · 1995 · 53 citations